Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-002317
Filing Date
2025-04-01
Accepted
2025-04-01 16:27:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4794
  Complete submission text file 0001950047-25-002317.txt   6259
Mailing Address 450 WEST 15 STREET SUITE 505 NEW YORK NY 10011
Business Address
Kapadia Sandip (Reporting) CIK: 0001677141 (see all company filings)

Type: 144

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Subject) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39450 | Film No.: 25800111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)